Continuous blood glucose monitors may not accurately detect low blood sugar, researchers found….

Patients with Type 1 diabetes who have repeated episodes of hypoglycemia appear to be at risk for early signs of atherosclerosis, researchers said….

Adding 50 mg of sitagliptin (Januvia) to pioglitazone (Actos) allowed patients with Type 2 diabetes to achieve sustained glycemic control, a yearlong trial showed….

Farnesoid X receptor agonists, 11-β-HSD1 inhibitors, and glucokinase activators are some of the new approaches to treating Type 2 diabetes described in research presented, but some senior researchers expressed doubts about the clinical need for them….

Once-Weekly Exenatide maintains a drop in A1c of 2 points for more than 52 weeks….

Intensive glucose control even after 10 years still shows clinical benefits and even rises over time….

A glass of merlot or perhaps sauvignon blanc with dinner may offer modest benefits for patients with Type 2 diabetes, said researchers….

Men are up to two and a half times more likely to have newly diagnosed Type 2 diabetes than women, but once a woman is diagnosed, the disease is just as deadly for them as for men…. 

Three possible first in class drugs in the sodium glucose co-transporter (SGLT2 inhibitor) class showed improvements in glycemic control and weight loss, but infections proved troublesome, researchers reported…. Michael Nauck, MD, and colleagues of Diabeteszentrum Bad Lauterberg in Harz, Germany, looked at studies involving three investigational drugs in the sodium …

Because Type 2 diabetes weakens the bone in often undetectable ways, both directly and indirectly via treatment side effects, experts urged increased awareness….